306 related articles for article (PubMed ID: 24681663)
1. Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1.
Krieger F; Elflein N; Saenger S; Wirthgen E; Rak K; Frantz S; Hoeflich A; Toyka KV; Metzger F; Jablonka S
Brain; 2014 May; 137(Pt 5):1374-93. PubMed ID: 24681663
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1).
Grohmann K; Rossoll W; Kobsar I; Holtmann B; Jablonka S; Wessig C; Stoltenburg-Didinger G; Fischer U; Hübner C; Martini R; Sendtner M
Hum Mol Genet; 2004 Sep; 13(18):2031-42. PubMed ID: 15269181
[TBL] [Abstract][Full Text] [Related]
3. The ultrastructure of peripheral nerve, motor end-plate and skeletal muscle in patients suffering from spinal muscular atrophy with respiratory distress type 1 (SMARD1).
Diers A; Kaczinski M; Grohmann K; Hübner C; Stoltenburg-Didinger G
Acta Neuropathol; 2005 Sep; 110(3):289-97. PubMed ID: 16025284
[TBL] [Abstract][Full Text] [Related]
4. Fast motor axon loss in SMARD1 does not correspond to morphological and functional alterations of the NMJ.
Krieger F; Elflein N; Ruiz R; Guerra J; Serrano AL; Asan E; Tabares L; Jablonka S
Neurobiol Dis; 2013 Jun; 54():169-82. PubMed ID: 23295857
[TBL] [Abstract][Full Text] [Related]
5. Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1.
Krieger F; Metzger F; Jablonka S
Rare Dis; 2014; 2():e29415. PubMed ID: 25083343
[TBL] [Abstract][Full Text] [Related]
6. Spinal muscular atrophy with respiratory distress type 1 (SMARD1).
Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K
J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757
[TBL] [Abstract][Full Text] [Related]
7. Treatment with trkC agonist antibodies delays disease progression in neuromuscular degeneration (nmd) mice.
Ruiz R; Lin J; Forgie A; Foletti D; Shelton D; Rosenthal A; Tabares L
Hum Mol Genet; 2005 Jul; 14(13):1825-37. PubMed ID: 15888478
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel severe mouse model of spinal muscular atrophy with respiratory distress type 1: FVB-nmd.
Shababi M; Smith CE; Kacher M; Alrawi Z; Villalón E; Davis D; Bryda EC; Lorson CL
Biochem Biophys Res Commun; 2019 Dec; 520(2):341-346. PubMed ID: 31604525
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1.
Grohmann K; Schuelke M; Diers A; Hoffmann K; Lucke B; Adams C; Bertini E; Leonhardt-Horti H; Muntoni F; Ouvrier R; Pfeufer A; Rossi R; Van Maldergem L; Wilmshurst JM; Wienker TF; Sendtner M; Rudnik-Schöneborn S; Zerres K; Hübner C
Nat Genet; 2001 Sep; 29(1):75-7. PubMed ID: 11528396
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
[TBL] [Abstract][Full Text] [Related]
11. Ciliary neurotrophic factor-induced sprouting preserves motor function in a mouse model of mild spinal muscular atrophy.
Simon CM; Jablonka S; Ruiz R; Tabares L; Sendtner M
Hum Mol Genet; 2010 Mar; 19(6):973-86. PubMed ID: 20022887
[TBL] [Abstract][Full Text] [Related]
12. Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy.
Maddatu TP; Garvey SM; Schroeder DG; Hampton TG; Cox GA
Hum Mol Genet; 2004 Jun; 13(11):1105-15. PubMed ID: 15069027
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of PEGylated insulin-like growth factor I in the pmn mouse model of motoneuron disease.
Jablonka S; Holtmann B; Sendtner M; Metzger F
Exp Neurol; 2011 Dec; 232(2):261-9. PubMed ID: 21963648
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1.
Vanoli F; Rinchetti P; Porro F; Parente V; Corti S
J Cell Mol Med; 2015 Sep; 19(9):2058-66. PubMed ID: 26095024
[TBL] [Abstract][Full Text] [Related]
15. Severe phenotypes of SMARD1 associated with novel mutations of the IGHMBP2 gene and nuclear degeneration of muscle and Schwann cells.
Jędrzejowska M; Madej-Pilarczyk A; Fidziańska A; Mierzewska H; Pronicka E; Obersztyn E; Gos M; Pronicki M; Kmieć T; Migdał M; Mierzewska-Schmidt M; Walczak-Wojtkowska I; Konopka E; Hausmanowa-Petrusewicz I
Eur J Paediatr Neurol; 2014 Mar; 18(2):183-92. PubMed ID: 24388491
[TBL] [Abstract][Full Text] [Related]
16. Growing up with spinal muscular atrophy with respiratory distress (SMARD1).
Hamilton MJ; Longman C; O'Hara A; Kirkpatrick M; McWilliam R
Neuromuscul Disord; 2015 Feb; 25(2):169-71. PubMed ID: 25454169
[TBL] [Abstract][Full Text] [Related]
17. Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis.
Guenther UP; Varon R; Schlicke M; Dutrannoy V; Volk A; Hübner C; von Au K; Schuelke M
Hum Mutat; 2007 Aug; 28(8):808-15. PubMed ID: 17431882
[TBL] [Abstract][Full Text] [Related]
18. Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent.
Shababi M; Feng Z; Villalon E; Sibigtroth CM; Osman EY; Miller MR; Williams-Simon PA; Lombardi A; Sass TH; Atkinson AK; Garcia ML; Ko CP; Lorson CL
Mol Ther; 2016 May; 24(5):855-66. PubMed ID: 26860981
[TBL] [Abstract][Full Text] [Related]
19. Infantile spinal muscular atrophy with respiratory distress type I presenting without respiratory involvement: Novel mutations and review of the literature.
Luan X; Huang X; Liu X; Zhou H; Chen S; Cao L
Brain Dev; 2016 Aug; 38(7):685-9. PubMed ID: 26922252
[TBL] [Abstract][Full Text] [Related]
20. Impaired Local Translation of β-actin mRNA in Ighmbp2-Deficient Motoneurons: Implications for Spinal Muscular Atrophy with respiratory Distress (SMARD1).
Surrey V; Zöller C; Lork AA; Moradi M; Balk S; Dombert B; Saal-Bauernschubert L; Briese M; Appenzeller S; Fischer U; Jablonka S
Neuroscience; 2018 Aug; 386():24-40. PubMed ID: 29928949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
